Department of Periodontics, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Department of Medicine, Graduate School, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Medicina (Kaunas). 2024 Oct 1;60(10):1610. doi: 10.3390/medicina60101610.
: Polydeoxyribonucleotides (PDRN), composed of DNA fragments derived from salmon DNA, is widely recognized for its regenerative properties. It has been extensively used in medical applications, such as dermatology and wound healing, due to its ability to enhance cellular metabolic activity, stimulate angiogenesis, and promote tissue regeneration. In the field of dentistry, PDRN has shown potential in promoting periodontal healing and bone regeneration. This study aims to investigate the effects of PDRN on the morphology, survival, and osteogenic differentiation of gingiva-derived stem cell spheroids, with a focus on its potential applications in tissue engineering and regenerative dentistry. : Gingiva-derived mesenchymal stem cells were cultured and formed into spheroids using microwells. The cells were treated with varying concentrations of PDRN (0, 25, 50, 75, and 100 μg/mL) and cultivated in osteogenic media. Cell morphology was observed over seven days using an inverted microscope, and viability was assessed with Live/Dead Kit assays and Cell Counting Kit-8. Osteogenic differentiation was evaluated by measuring alkaline phosphatase activity and calcium deposition. The expression levels of osteogenic markers RUNX2 and COL1A1 were quantified using real-time polymerase chain reaction. RNA sequencing was performed to assess the gene expression profiles related to osteogenesis. : The results demonstrated that PDRN treatment had no significant effect on spheroid diameter or cellular viability during the observation period. However, a PDRN concentration of 75 μg/mL significantly enhanced calcium deposition by Day 14, suggesting increased mineralization. RUNX2 and COL1A1 mRNA expression levels varied with PDRN concentration, with the highest RUNX2 expression observed at 25 μg/mL and the highest COL1A1 expression at 75 μg/mL. RNA sequencing further confirmed the upregulation of genes involved in osteogenic differentiation, with enhanced expression of RUNX2 and COL1A1 in PDRN-treated gingiva-derived stem cell spheroids. : In summary, PDRN did not significantly affect the viability or morphology of gingiva-derived stem cell spheroids but influenced their osteogenic differentiation and mineralization in a concentration-dependent manner. These findings suggest that PDRN may play a role in promoting osteogenic processes in tissue engineering and regenerative dentistry applications, with specific effects observed at different concentrations.
聚脱氧核糖核苷酸(PDRN)由源自鲑鱼 DNA 的 DNA 片段组成,因其具有再生特性而广为人知。由于其能够增强细胞代谢活性、刺激血管生成和促进组织再生,因此已广泛应用于医学领域,如皮肤科和伤口愈合。在牙科领域,PDRN 已显示出在促进牙周愈合和骨再生方面的潜力。本研究旨在探讨 PDRN 对牙龈间充质干细胞球体形态、存活和成骨分化的影响,重点研究其在组织工程和再生牙科中的潜在应用。
将牙龈间充质干细胞培养并在微井中形成球体。用不同浓度的 PDRN(0、25、50、75 和 100 μg/mL)处理细胞,并在成骨培养基中培养。使用倒置显微镜在七天内观察细胞形态,并用 Live/Dead 试剂盒和细胞计数试剂盒-8 评估细胞活力。通过测量碱性磷酸酶活性和钙沉积来评估成骨分化。使用实时聚合酶链反应定量测定成骨标志物 RUNX2 和 COL1A1 的表达水平。进行 RNA 测序以评估与成骨相关的基因表达谱。
结果表明,在观察期间,PDRN 处理对球体直径或细胞活力没有显著影响。然而,75 μg/mL 的 PDRN 浓度在第 14 天显著增加钙沉积,表明矿化增加。RUNX2 和 COL1A1 的 mRNA 表达水平随 PDRN 浓度而变化,在 25 μg/mL 时观察到最高的 RUNX2 表达,在 75 μg/mL 时观察到最高的 COL1A1 表达。RNA 测序进一步证实了与成骨分化相关基因的上调,PDRN 处理的牙龈间充质干细胞球体中 RUNX2 和 COL1A1 的表达增强。
总之,PDRN 对牙龈间充质干细胞球体的活力或形态没有显著影响,但以浓度依赖的方式影响其成骨分化和矿化。这些发现表明,PDRN 可能在组织工程和再生牙科应用中促进成骨过程发挥作用,在不同浓度下观察到特定的作用。